M&A

M&A: Fundamental to Pharma Industry Growth

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Nice Insight

Understanding a Dynamic Industry Through Mergers and Acquisitions

Nigel Walker

Nice Insight

Pharmaceutics

Pharmaceutics Know-How and Service Excellence to Re-Energize a CDMO

Kurt R. Nielsen, Ph.D.

Pii

AAV Vector Production

Challenges to Process Validation for Viral Vectors

Kyle Zingaro, Ph.D.; Deborah Mar Begos; Todd Miller

Thermo Fisher Scientific

CDMO Leadership

A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership

Frank Mathias, Ph.D.

Rentschler Biopharma SE

Excipients

New Mannitol Formulations Are a Gem of a Collection

Graeme MacLeod; Bill McCarthy

SPI Pharma

Virtual Panel

Leveraging a Biomanufacturing Legacy to Support New Business

Grifols Recombinant Protein CDMO

Microbiome

Reflections on a 10-Year Journey in the Microbiome

Aaron B. Cowley, Ph.D.

Arranta Bio

Business Models

CDMO Services Designed to Support Evolving Pharma Business Models

Patrice Martin

Servier

Small-Volume

Benefits of Integrated Small-Volume Manufacturing Capabilities

James J. Springer, Ph.D.; Mitch Kenyon; Tyler Kerr; James Goodwin

Albemarle Fine Chemistry Services

Tracking

Proprietary Tracking and Visibility Tools Ensure Secure Transportation

Marc Boyle

Boyle Transportation

Continuous Improvement

The Critical Role of Continuous Improvement in Parenteral Drug Manufacturing

Antonio A. Gomez

Grifols

Drug Development

A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways

Jonathan Reis, Ph.D.

ASD

Small-Scale Screening Technology for Amorphous Solid Dispersion Development

Daniel Treffer, Ph.D.

MeltPrep

Bioinformatics

Leveraging Bioinformatics for Nontraditional Drug Discovery

Ben Zeskind, Ph.D

Immuneering Corporation

RNA Biomarkers

RNA Biomarkers for Early Lung Cancer Diagnosis

Ron Andrews

OncoCyte

Immune Therapies

An R&D Engine for Novel Immune Therapies

Alexis Peyroles

OSE Immunotherapeutics

In Conversation

NantKwest — Harnessing Natural Killer Cells to Treat Cancer

Emilie Branch; Gary Lord; Dago Caceres; Patrick Soon-Shiong, M.D.

Pharma's Almanac

Process Engineering

Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation

Scott Doncaster; Clarke MacDonald

BIOVECTRA

Cancer Screening

Innovating to Increase Adherence for Colon Cancer Screening

Alex Ovadia

Check-Cap